Given the following information, prepare a trial balance for Abbott Laboratories as of December 31, 2024:

Account	Debit ($)	Credit ($)
Cash	$410,050,000
Accounts Receivable	$415,000,000
Inventory	$370,050,000
Equipment	$1,480,050,000
Accumulated Depreciation		$710,000,000
Accounts Payable		$660,000,000
Notes Payable		$1,400,040,000
Common Stock		$1,700,000,000
Retained Earnings		$743,000,000
Sales Revenue		$1,800,050,000
Cost of Goods Sold	$900,000,000
Operating Expenses	$670,500,000